In December 2023, Eli Lilly and Company, one of the major GLP-1 receptor agonist companies, announced the availability of Zepbound (tirzepatide) injection, a GLP-1 drug, in the U.S
Concomitantly, we measured increased pyruvate levels in mutant compared to control cells (Supplementary Fig
When to Consider Other Hair Loss Treatments Sometimes, PRP is the star of the show, and other times it plays a supporting role in a more comprehensive hair restoration plan
Additionally, about one-fifth of adults who use GLP-1 agonists reported having experienced vomiting
(1,2) GLP-1 loves fibre, but before we go into why, lets do a quick review